scholarly journals The Role of Immune Cell Types in Ischemic Heart Disease Progression: A Systematic Review

2021 ◽  
Vol 5 (10) ◽  
pp. 1-9
Author(s):  
Jenny Liu ◽  
Vaneeza Moosa ◽  
Isabelle Tan
Keyword(s):  
Systematic Review ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Disease Progression ◽  
Immune Cell ◽  
Cell Types ◽  
Ischemic Heart

scholarly journals Role of Imaging in the Management of Stable Ischemic Heart Disease

2017 ◽  
Vol 10 (3) ◽  
pp. 335-337 ◽  
Author(s):  
William E. Boden ◽  
Judith L. Meadows
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Ischemic Heart ◽  
Stable Ischemic Heart Disease

scholarly journals Early life programming of adult ischemic heart disease within and across generations: the role of the socioeconomic context

2021 ◽  
pp. 113811
Author(s):  
Muhammad Zakir Hossin ◽  
Daniel Falkstedt ◽  
Peter Allebeck ◽  
Gita Mishra ◽  
Ilona Koupil
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Early Life ◽  
Ischemic Heart ◽  
Socioeconomic Context ◽  
Early Life Programming

The role of clopidogrel in the management of ischemic heart disease

2007 ◽  
Vol 6 (5) ◽  
pp. 454-460 ◽  
Author(s):  
John M Galla ◽  
A Michael Lincoff
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Ischemic Heart

scholarly journals Mobile Phone Technologies in the Management of Ischemic Heart Disease, Heart Failure, and Hypertension: Systematic Review and Meta-Analysis

10.2196/16695 ◽  
2020 ◽  
Vol 8 (7) ◽  
pp. e16695 ◽  
Author(s):  
Praveen Indraratna ◽  
Daniel Tardo ◽  
Jennifer Yu ◽  
Kim Delbaere ◽  
Matthew Brodie ◽  
...  
Keyword(s):  
Heart Failure ◽  
Systematic Review ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Mobile Phone ◽  
Meta Analysis ◽  
Random Effect ◽  
Random Effect Model ◽  
Ischemic Heart ◽  
Valuable Adjunct

Background Cardiovascular disease (CVD) remains the leading cause of death worldwide. Mobile phones have become ubiquitous in most developed societies. Smartphone apps, telemonitoring, and clinician-driven SMS allow for novel opportunities and methods in managing chronic CVD, such as ischemic heart disease, heart failure, and hypertension, and in the conduct and support of cardiac rehabilitation. Objective A systematic review was conducted using seven electronic databases, identifying all relevant randomized control trials (RCTs) featuring a mobile phone intervention (MPI) used in the management of chronic CVD. Outcomes assessed included mortality, hospitalizations, blood pressure (BP), and BMI. Methods Electronic data searches were performed using seven databases from January 2000 to June 2019. Relevant articles were reviewed and analyzed. Meta-analysis was performed using standard techniques. The odds ratio (OR) was used as a summary statistic for dichotomous variables. A random effect model was used. Results A total of 26 RCTs including 6713 patients were identified and are described in this review, and 12 RCTs were included in the meta-analysis. In patients with heart failure, MPIs were associated with a significantly lower rate of hospitalizations (244/792, 30.8% vs 287/803, 35.7%; n=1595; OR 0.77, 95% CI 0.62 to 0.97; P=.03; I2=0%). In patients with hypertension, patients exposed to MPIs had a significantly lower systolic BP (mean difference 4.3 mm Hg; 95% CI −7.8 to −0.78 mm Hg; n=2023; P=.02). Conclusions The available data suggest that MPIs may have a role as a valuable adjunct in the management of chronic CVD.

Sign in / Sign up

Export Citation Format

Share Document